Exhibit 1281 ยท Statute
FDA Reauthorization Act of 2017, Pub. L. 115-52, Title I (Prescription Drug User Fee Amendments of 2017)
The Congress finds that the fees authorized by the amendments made in this title will be dedicated toward expediting the drug development process and the process for the review of human drug applications, including postmarket drug safety activities
Title I is the Prescription Drug User Fee Amendments of 2017 (PDUFA VI). Approved 18 August 2017.
- Source
- United States Congress
- Date
- 18 August 2017
- Quoted from
- Sec. 101(b)
- Grade
- Primary record
- Document
- https://www.govinfo.gov/content/pkg/PLAW-115publ52/html/PLAW-115publ52.htm
- Accessed
- 2026-11-10
- Cited by
- Findings citing this exhibit